{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:26:37Z","timestamp":1782602797153,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Nature Science Foundation","doi-asserted-by":"crossref","award":["2014A030313193"],"award-info":[{"award-number":["2014A030313193"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.breast.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T23:18:13Z","timestamp":1502234293000},"page":"191-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Liver toxicity of chemotherapy and targeted therapy for breast cancer patients with hepatitis virus infection"],"prefix":"10.1016","volume":"35","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun-Ai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2017.08.001_bib1","series-title":"Guidelines for the screening, care and treatment of persons with hepatitis C infection","author":"WHO","year":"2014"},{"key":"10.1016\/j.breast.2017.08.001_bib2","series-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","author":"WHO","year":"2015"},{"issue":"12","key":"10.1016\/j.breast.2017.08.001_bib3","first-page":"888","article-title":"The guideline of prevention and treatment for chronic hepatitis B: a 2015 update","volume":"23","author":"Chinese Society of Hepatology","year":"2015","journal-title":"Chin J Hepatol"},{"issue":"12","key":"10.1016\/j.breast.2017.08.001_bib4","first-page":"906","article-title":"The guideline of prevention and treatment for chronic hepatitis C: a 2015 update","volume":"23","author":"Chinese Society of Hepatology","year":"2015","journal-title":"Chin J Hepatol"},{"key":"10.1016\/j.breast.2017.08.001_bib5","first-page":"466","article-title":"Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries","volume":"6","author":"Zeng","year":"2014","journal-title":"J\u00a0Thorac Dis"},{"issue":"27","key":"10.1016\/j.breast.2017.08.001_bib6","first-page":"2","article-title":"Annual report on status of cancer in China","volume":"2015","author":"Chen","year":"2011","journal-title":"Chin J Cancer Res"},{"issue":"64","key":"10.1016\/j.breast.2017.08.001_bib7","first-page":"52","article-title":"Breast cancer statistics","volume":"2014","author":"DeSantis","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2017.08.001_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","article-title":"Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy","volume":"148","author":"Loomba","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.breast.2017.08.001_bib9","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","article-title":"Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis","volume":"116","author":"Ennishi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.breast.2017.08.001_bib10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2012.07.031","article-title":"Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients","volume":"57","author":"Mahale","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.breast.2017.08.001_bib11","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1634\/theoncologist.2012-0187","article-title":"The effect of transcatheter arterial chemoembolization on hepatitis C viremia","volume":"17","author":"Mahale","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.breast.2017.08.001_bib12","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.breast.2017.08.001_bib13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cncr.20850","article-title":"HER-2\/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger","volume":"103","author":"Maru","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2017.08.001_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/2007-131-18-ASOCCO","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"131","author":"Wolff","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.breast.2017.08.001_bib15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10549-011-1455-9","article-title":"A\u00a0single-center, prospective and randomized controlled study: can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?","volume":"127","author":"Long","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2017.08.001_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-004-0725-1","article-title":"Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients","volume":"88","author":"Yeo","year":"2004","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.breast.2017.08.001_bib17","first-page":"519","article-title":"The safety of chemotherapy for breast cancer patients with hepatitis C virus infection","volume":"4","author":"Miura","year":"2013","journal-title":"J\u00a0Cancer"},{"issue":"7","key":"10.1016\/j.breast.2017.08.001_bib18","first-page":"3715","article-title":"Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer","volume":"34","author":"Levaggi","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.breast.2017.08.001_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3748\/wjg.v19.i6.923","article-title":"Testing for hepatitis B infection in prospective chemotherapy patients: a retrospective study","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.breast.2017.08.001_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1432-2277.2009.01025.x","article-title":"No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients","volume":"23","author":"Nicot","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.breast.2017.08.001_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clim.2005.08.006","article-title":"The therapeutic potential of anti-CD20 \u201cwhat do B-cells do?\u201d","volume":"117","author":"Eisenberg","year":"2005","journal-title":"Clin Immunol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.breast.2017.08.001_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.11-90001-4","article-title":"Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer","volume":"11","author":"Baselga","year":"2006","journal-title":"Oncologist"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.breast.2017.08.001_bib23","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/j.breast.2013.07.029","article-title":"Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies","volume":"22","author":"Pinto","year":"2013","journal-title":"Breast"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617305507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977617305507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:39:34Z","timestamp":1760776774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977617305507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":23,"alternative-id":["S0960977617305507"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2017.08.001","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver toxicity of chemotherapy and targeted therapy for breast cancer patients with hepatitis virus infection","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}